Urinary Frequency clinical trials at University of California Health

1 research study open to eligible people

Sacral Neuromodulation for Male Overactive Bladder (MOAB)
open to eligible males ages 18 years and up
To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.
at UCSF

Our lead scientists for Urinary Frequency research studies include Michelle Van Kuiken, MD.

Last updated: September 10, 2026